Veterinary Therapeutics Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)

  • Category : Medical Devices
  • |
  • ID : 1011838
  • |
  • Publishe Date : 14-May-19
  • |
  • No of Pages: 55
  • |
  • Publisher : 99strategy

According to 99Strategy, the Global Veterinary Therapeutics Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Veterinary Therapeutics market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Bayer AG
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Eli Lilly and Company (Elanco Animal Health)
Merck Animal Health
Sanofi (Merial Animal Health)
Virbac
Vetoquinol S.A.
Zoetis, Inc.
Key Product Type
Anti-inflammatory
Parasiticides
Others
Market by Vaccines
Inactivated Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Market by Application
Hospitals
Veterinary Clinics
Drug Stores
Main Aspects covered in the Report
Overview of the Veterinary Therapeutics market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development

Table of Content
1 Industrial Chain Overview
1.1 Veterinary Therapeutics Industry
1.1.1 Overview
1.1.2 Characteristics of Veterinary Therapeutics
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Drugs
1.3.1 Anti-inflammatory
1.3.2 Parasiticides
1.3.3 Others
1.4 Product List By Vaccines
1.4.1 Inactivated Vaccines
1.4.2 Live Attenuated Vaccines
1.4.3 Recombinant Vaccines
1.5 End-Use List
1.5.1 Demand in Hospitals
1.5.2 Demand in Veterinary Clinics
1.5.3 Demand in Drug Stores
1.6 Global Market Overview
1.6.1 Global Market Size and Forecast, 2015-2025
1.6.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.6.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.6.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 Bayer AG Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 Boehringer Ingelheim GmbH Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 Ceva Sante Animale Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Dechra Pharmaceuticals PLC Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 Eli Lilly and Company (Elanco Animal Health) Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Merck Animal Health Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 Sanofi (Merial Animal Health) Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Virbac Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Vetoquinol S.A. Overview
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Zoetis, Inc. Overview
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Drugs
5.2.1 Market in Anti-inflammatory
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in Parasiticides
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in Others
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.3 Segment Subdivision by Vaccines
5.3.1 Market in Inactivated Vaccines
5.3.1.1 Market Size
5.3.1.2 Situation & Development
5.3.2 Market in Live Attenuated Vaccines
5.3.2.1 Market Size
5.3.2.2 Situation & Development
5.3.3 Market in Recombinant Vaccines
5.3.3.1 Market Size
5.3.3.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Hospitals
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Veterinary Clinics
6.2.2.1 Market Size
6.2.2.2 Situation & Development
6.2.3 Market in Drug Stores
6.2.3.1 Market Size
6.2.3.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast by Drugs
7.2.2 Product Type Forecast by Vaccines
7.2.3 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
10 Research Conclusion

Content are not available

Choose License Type